Division of Urology, Department of Surgery, Chi-Mei Medical Center, Tainan, Taiwan, ROC.
J Chin Med Assoc. 2011 Apr;74(4):155-8. doi: 10.1016/j.jcma.2011.01.035. Epub 2011 Mar 15.
Radical retropubic prostatectomy remains the gold standard treatment for localized prostate cancer. However, new minimally invasive techniques have emerged, providing a less invasive approach. Robotic-assisted laparoscopic radical prostatectomy is the ideal technique, providing good oncologic and functional outcomes. We analyzed the impact of robotic surgical systems on practice patterns among urologists to explain changes in the value of radical retropubic prostatectomy, laparoscopic radical prostatectomy and robotic-assisted laparoscopic radical prostatectomy in a single institution in Taiwan.
We retrospectively reviewed the records of patients who received prostatectomy by one of the above procedures between January 2004 and November 2009. Decisions to perform these procedures were made by patient preference. Patients who received prostate biopsies at other hospitals were transferred to our hospital specifically for robotic-assisted prostatectomy.
A total of 434 radical prostatectomies were performed, of which 141 (32.49%) were radical retropubic prostatectomies, 59 (13.59%) were laparoscopic radical prostatectomies and 234 (53.92%) were robotic-assisted laparoscopic prostatectomies. The overall number of prostatectomies has increased over time because of an increase in robotic-assisted procedures. No decreases were seen in the number of radical retropubic prostatectomies during the evaluation period. Changes in the ratio of robotic-assisted prostatectomies compared to radical retropubic and laparoscopic radical prostatectomies demonstrated a trend toward robotic-assisted procedures. The percentage of cases transferred from other hospitals also increased over time from 28.57% to 68.60%.
Our experience emphasizes the potential of robotic-assisted prostatectomy to become the mainstream treatment for localized prostate cancer in Taiwan.
根治性耻骨后前列腺切除术仍然是局限性前列腺癌的金标准治疗方法。然而,新的微创技术已经出现,提供了一种侵袭性较小的方法。机器人辅助腹腔镜根治性前列腺切除术是理想的技术,提供了良好的肿瘤学和功能结果。我们分析了机器人手术系统对泌尿科医生实践模式的影响,以解释在台湾的一家单机构中,根治性耻骨后前列腺切除术、腹腔镜根治性前列腺切除术和机器人辅助腹腔镜根治性前列腺切除术的价值变化。
我们回顾性地审查了 2004 年 1 月至 2009 年 11 月期间接受上述手术之一的患者的记录。选择这些手术是基于患者的偏好。在其他医院接受前列腺活检的患者被转介到我们医院专门进行机器人辅助前列腺切除术。
共进行了 434 例前列腺切除术,其中 141 例(32.49%)为根治性耻骨后前列腺切除术,59 例(13.59%)为腹腔镜根治性前列腺切除术,234 例(53.92%)为机器人辅助腹腔镜前列腺切除术。由于机器人辅助手术的增加,前列腺切除术的总数随着时间的推移而增加。在评估期间,根治性耻骨后前列腺切除术的数量没有减少。机器人辅助前列腺切除术与根治性耻骨后和腹腔镜根治性前列腺切除术的比例变化显示出向机器人辅助手术的趋势。从其他医院转介的病例比例也从 28.57%增加到 68.60%。
我们的经验强调了机器人辅助前列腺切除术有可能成为台湾局限性前列腺癌的主流治疗方法。